A New Clinical Tool for Scoliosis Risk Analysis: Scoliosis Tele-Screening Test

STUDY DESIGN

Methodological, observational clinical study.

PURPOSE

This study aimed to develop a virtual screening test to detect scoliosis risk initially by parents without the need for medical visit during the coronavirus disease 2019 pandemic.

OVERVIEW OF LITERATURE

The scoliosis screening program has been implemented to early detect scoliosis. Unfortunately, access to health professionals was limited during the pandemic. However, during this time, interest in telemedicine has increased remarkably. Recently, mobile applications related to postural analysis were developed, but none permits evaluation by parents.

METHODS

Researchers developed the Scoliosis Tele-Screening Test (STS-Test), which included drawing-based images of body asymmetries, to assess the scoliosis-associated risk factors. The STS-Test was shared on social networks, allowing the parents to evaluate their children. After test completion, the risk score was generated automatically, and children with medium and high risks were then advised for medical consultation for further evaluation. The test accuracy and consistency between the clinician and parents were also analyzed.

RESULTS

Of the 865 tested children, 358 (41.4%) consulted clinicians to confirm their STS-Test results. Scoliosis was then confirmed in 91 children (25.4%). The parents were able to detect asymmetry in 50% of the lumbar/thoracolumbar curvatures and 82% of the thoracic curvatures. In addition, the forward bend test revealed favorable agreement between parents and clinicians (r =0.809, p<0.0005). Internal consistency of the esthetic deformities domain in the STS-Test was also excellent (α=0.901). This tool was 94.97% accurate, 83.51% sensitive, and 98.87% specific.

CONCLUSIONS

The STS-Test is a new parent-friendly, virtual, cost-effective, result-oriented, and reliable tool for scoliosis screening. It allows parents to actively participate in the early detection of scoliosis by screening their children for the risk of scoliosis periodically without the need to visit the health institution.

Vortex keratopathy associated with ribociclib

INTRODUCTION

Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors are the new generation drugs that have been started to be used in our clinical practice recently. These drugs have been shown to have better progression-free survival compared to standard therapy in patients with hormone receptor-positive (HR) and human epidermal growth factor receptor 2 (HER-2)-negative breast cancer. The most common side effects of CDK 4-6 inhibitors are neutropenia, nausea, leukopenia, fatigue, and diarrhea. This case demonstrated vortex keratopathy in both eyes, a rare condition in patients with breast cancer treated with ribociclib.

CASE REPORT

A 68-year-old female patient was diagnosed with locally advanced HR (+)/HER2 (-) breast cancer in March 2015. In June 2021, bone metastases were detected. The patient was started on ribociclib and fulvestrant. After three cycles of ribociclib and fulvestrant treatment, she was admitted with the complaint of blurred vision in her left eye. Slit-lamp biomicroscopy examination revealed subepithelial haze with central subepithelial whorls in both corneas, more in the left eye, and also a mild punctate epithelial staining was observed with the application of fluorescein dye.

MANAGEMENT AND OUTCOME

Ribociclib treatment was immediately discontinued and no changes were observed in the cornea and vision levels during the one-month follow-up.

DISCUSSION

Routine and regular follow-up eye examinations in breast cancer patients treated with ribociclib may benefit patients in our daily clinical practice and may help us to detect side effects at an early stage and to manage them more effectively.

Analysis of corneal biomechanical properties 25 years after myopic photorefractive keratectomy

PURPOSE

To evaluate corneal biomechanical changes using Corvis ST in patients treated with photorefractive keratectomy (PRK) 25 years ago.

METHODS

In this study, 32 post-PRK and 38 normal eyes underwent Corvis ST (CST) assessments. The measured CST factors were: time of highest concavity (HC), time of applanation 1 (AT1), time of applanation 2 (AT2), length of applanation 1 (AL1), length of applanation 2 (AL2), velocity of applanation 1 (AV1), velocity of applanation 2 (AV2), deformation amplitude (DA), peak distance (PD), integrated radius (IR), Ambrosio relational thickness horizontal (ARTh), stiffness parameter at first applanation (SP-A1), DA ratio (2 mm), Belin/Ambrosio enhanced ectasia display (BAD) and corneal biomechanical index (CBI).

RESULTS

The mean [± standard deviation (SD)] age was 51.4 ± 7.36 years in PRK, 51.4 ± 3.62 in control group. PRK was performed 24.69 ± 1.78 years ago. ARTh, SP-A1, AT1, AL1, and AL2 were lower in PRK. PD, AT2, DA ratio (2 mm), and IR were statistically higher in PRK (P < 0.01). In PRK and control group the mean value of CBI was 0.91 ± 0.11 and 0.50 ± 0.27 (P < 0.001), and mean value of BAD was 3.34 ± 1.53 and 1.1 ± 0.70 (P < 0.001). In PRK 71.9% of eyes were classed "high risk CBI plus diseased BAD" and 25% remained in the "high risk CBI and normal BAD" group.

CONCLUSIONS

In this study, most of the post-PRK eyes which were clinically and topographically normal were classified as "high risk CBI plus diseased BAD" and had significantly worse CBI and BAD values than the control group. This leads to the conclusion that CBI and BAD alone are not appropriate to evaluate post-PRK ectasia.

Evaluation of diplopia as a vital and remarkable ocular finding among cancer patients

BACKGROUND

Diplopia is an important and debilitating symptom of malignancies due to different pathogenetic mechanisms. Data is lacking in the literature because of the rarity of the diplopia in patients with cancer.

AIMS

We aimed to evaluate the etiological and clinical factors of diplopia in patients with different types of cancer.

METHODS

We retrospectively investigated 22 cancer patients with diplopia who were admitted between 2018 and 2021. The diagnosis of primary cancer, the underlying factors causing diplopia, and the life expectancy after diplopia were evaluated.

RESULTS

Among available data of 620 cancer patients applied to our ophthalmology department, 22 (3.55%) had diplopia. Paralytic strabismus was found in 19 patients and restrictive strabismus was found in 3 patients. Among the paralytic cases, 6th nerve palsy was found to be the most common with a rate of 68%. In 18 of 22 (82%) patients, the cause of diplopia was due to orbital or brain metastasis or local invasion. Two patients had diplopia secondary to radiotherapy and 2 had diplopia due to chemotherapy.

CONCLUSION

Metastasis is the most common cause of diplopia in patients with cancer and screening for metastasis is crucial as soon as diplopia begins for a better life expectancy.